INVO Bioscience Inc
NASDAQ:INVO
| Market Cap (Intraday) | 47.32M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.69 |
| 50-Day MA | $3.72 |
| 200-Day MA | $3.99 |
INVO Bioscience Inc Stock, NASDAQ:INVO
5582 Broadcast Court, Suite 34C, Sarasota, Florida 34240
United States of America
Phone: +1.978.878.9505
Number of Employees: 10
Description
INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Sarasota, FL.